

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sperm motility (GO:0030317) | 6.36187814 |
| 2 | acrosome reaction (GO:0007340) | 6.10535765 |
| 3 | cilium or flagellum-dependent cell motility (GO:0001539) | 6.10444814 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 5.97941930 |
| 5 | acrosome assembly (GO:0001675) | 5.21641132 |
| 6 | sperm-egg recognition (GO:0035036) | 5.21326416 |
| 7 | axonemal dynein complex assembly (GO:0070286) | 4.94702812 |
| 8 | plasma membrane fusion (GO:0045026) | 4.93153317 |
| 9 | cell-cell recognition (GO:0009988) | 4.73035299 |
| 10 | binding of sperm to zona pellucida (GO:0007339) | 4.68384291 |
| 11 | cell wall macromolecule catabolic process (GO:0016998) | 4.67024429 |
| 12 | cell wall macromolecule metabolic process (GO:0044036) | 4.67024429 |
| 13 | motile cilium assembly (GO:0044458) | 4.65946207 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 4.63498932 |
| 15 | piRNA metabolic process (GO:0034587) | 4.51858454 |
| 16 | multicellular organism reproduction (GO:0032504) | 4.50257760 |
| 17 | regulation of cilium movement (GO:0003352) | 4.49179112 |
| 18 | spermatid development (GO:0007286) | 4.32165370 |
| 19 | carnitine transmembrane transport (GO:1902603) | 4.25213127 |
| 20 | amino-acid betaine transport (GO:0015838) | 4.21352862 |
| 21 | carnitine transport (GO:0015879) | 4.21352862 |
| 22 | calcium ion-dependent exocytosis (GO:0017156) | 4.14812190 |
| 23 | epithelial cilium movement (GO:0003351) | 4.07361382 |
| 24 | synaptonemal complex organization (GO:0070193) | 4.01764469 |
| 25 | organic cation transport (GO:0015695) | 4.00437263 |
| 26 | male meiosis (GO:0007140) | 3.98211824 |
| 27 | sperm capacitation (GO:0048240) | 3.93367172 |
| 28 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.92785250 |
| 29 | negative regulation of inclusion body assembly (GO:0090084) | 3.85105990 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.80754518 |
| 31 | reproduction (GO:0000003) | 3.80562694 |
| 32 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.74422078 |
| 33 | synaptonemal complex assembly (GO:0007130) | 3.64635668 |
| 34 | carnitine shuttle (GO:0006853) | 3.58478458 |
| 35 | mannose metabolic process (GO:0006013) | 3.55758140 |
| 36 | aspartate family amino acid catabolic process (GO:0009068) | 3.55719835 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.53508153 |
| 38 | cilium movement (GO:0003341) | 3.51014145 |
| 39 | succinate metabolic process (GO:0006105) | 3.42655086 |
| 40 | barbed-end actin filament capping (GO:0051016) | 3.40948919 |
| 41 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.39880169 |
| 42 | glycolytic process (GO:0006096) | 3.36116706 |
| 43 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.34679547 |
| 44 | regulation of inclusion body assembly (GO:0090083) | 3.34653829 |
| 45 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.34599010 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32805421 |
| 47 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32077044 |
| 48 | synaptic vesicle maturation (GO:0016188) | 3.30577668 |
| 49 | lactate metabolic process (GO:0006089) | 3.25743481 |
| 50 | quaternary ammonium group transport (GO:0015697) | 3.22133933 |
| 51 | NADH metabolic process (GO:0006734) | 3.19775367 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 3.17277584 |
| 53 | protein localization to endosome (GO:0036010) | 3.15660237 |
| 54 | cell communication by electrical coupling (GO:0010644) | 3.15045435 |
| 55 | oxaloacetate metabolic process (GO:0006107) | 3.14488630 |
| 56 | regulation of microtubule-based movement (GO:0060632) | 3.12647212 |
| 57 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.12355521 |
| 58 | membrane depolarization during action potential (GO:0086010) | 3.12351228 |
| 59 | glutamate secretion (GO:0014047) | 3.11966350 |
| 60 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.11269070 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09796572 |
| 62 | negative regulation of cell killing (GO:0031342) | 3.09796572 |
| 63 | negative regulation of cell size (GO:0045792) | 3.06322015 |
| 64 | fatty acid transmembrane transport (GO:1902001) | 3.05165698 |
| 65 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.99877002 |
| 66 | single fertilization (GO:0007338) | 2.99739974 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.98795923 |
| 68 | regulation of synapse structural plasticity (GO:0051823) | 2.97575748 |
| 69 | lysine metabolic process (GO:0006553) | 2.97324990 |
| 70 | lysine catabolic process (GO:0006554) | 2.97324990 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.94637223 |
| 72 | 2-oxoglutarate metabolic process (GO:0006103) | 2.90817038 |
| 73 | regulation of fatty acid oxidation (GO:0046320) | 2.89849664 |
| 74 | gluconeogenesis (GO:0006094) | 2.89825776 |
| 75 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.89775979 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.88383713 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.88383713 |
| 78 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.88352829 |
| 79 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85334840 |
| 80 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.83806642 |
| 81 | sodium ion export (GO:0071436) | 2.83722144 |
| 82 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.81812357 |
| 83 | regulation of oxidative phosphorylation (GO:0002082) | 2.79947183 |
| 84 | pyruvate metabolic process (GO:0006090) | 2.79757787 |
| 85 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.76616665 |
| 86 | locomotory exploration behavior (GO:0035641) | 2.76466619 |
| 87 | activation of protein kinase A activity (GO:0034199) | 2.75352080 |
| 88 | hexose biosynthetic process (GO:0019319) | 2.73831811 |
| 89 | response to peptidoglycan (GO:0032494) | 2.72744162 |
| 90 | regulation of synaptic vesicle transport (GO:1902803) | 2.72524534 |
| 91 | spermatogenesis (GO:0007283) | 2.71824758 |
| 92 | Golgi transport vesicle coating (GO:0048200) | 2.71362118 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 2.71362118 |
| 94 | male gamete generation (GO:0048232) | 2.70289627 |
| 95 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.69478265 |
| 96 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.69114823 |
| 97 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.68819667 |
| 98 | cell recognition (GO:0008037) | 2.67758921 |
| 99 | response to pheromone (GO:0019236) | 2.67510786 |
| 100 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.67122074 |
| 101 | detection of bacterium (GO:0016045) | 2.66755507 |
| 102 | stress fiber assembly (GO:0043149) | 2.65400038 |
| 103 | modulation by symbiont of host cellular process (GO:0044068) | 2.64809443 |
| 104 | pinocytosis (GO:0006907) | 2.63574632 |
| 105 | fructose metabolic process (GO:0006000) | 2.62664469 |
| 106 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.61039059 |
| 107 | left/right pattern formation (GO:0060972) | 2.60594913 |
| 108 | tricarboxylic acid metabolic process (GO:0072350) | 2.60553188 |
| 109 | detection of other organism (GO:0098543) | 2.60196959 |
| 110 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.59944472 |
| 111 | modulation by symbiont of host immune response (GO:0052553) | 2.59944472 |
| 112 | positive regulation by symbiont of host defense response (GO:0052509) | 2.59944472 |
| 113 | modulation by symbiont of host defense response (GO:0052031) | 2.59944472 |
| 114 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.59944472 |
| 115 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.59944472 |
| 116 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.59794925 |
| 117 | neurotransmitter secretion (GO:0007269) | 2.59243455 |
| 118 | DNA methylation involved in gamete generation (GO:0043046) | 2.59197307 |
| 119 | urea cycle (GO:0000050) | 2.59183957 |
| 120 | sarcomere organization (GO:0045214) | 2.58861729 |
| 121 | positive regulation of receptor recycling (GO:0001921) | 2.58825679 |
| 122 | glycosphingolipid catabolic process (GO:0046479) | 2.57956466 |
| 123 | peptide catabolic process (GO:0043171) | 2.57573684 |
| 124 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.57250626 |
| 125 | dicarboxylic acid catabolic process (GO:0043649) | 2.56239845 |
| 126 | response to thyroid hormone (GO:0097066) | 2.55800545 |
| 127 | fertilization (GO:0009566) | 2.55419493 |
| 128 | carnitine metabolic process (GO:0009437) | 2.55407042 |
| 129 | regulation of membrane repolarization (GO:0060306) | 2.54947530 |
| 130 | response to laminar fluid shear stress (GO:0034616) | 2.54425228 |
| 131 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53534831 |
| 132 | negative regulation of organelle assembly (GO:1902116) | 2.51922092 |
| 133 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.51651449 |
| 134 | alpha-linolenic acid metabolic process (GO:0036109) | 2.50556966 |
| 135 | cellular potassium ion homeostasis (GO:0030007) | 2.50275999 |
| 136 | apoptotic process involved in morphogenesis (GO:0060561) | 2.49027047 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 2.48901165 |
| 138 | cardiac muscle contraction (GO:0060048) | 2.48302178 |
| 139 | microtubule severing (GO:0051013) | 2.47742554 |
| 140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.47513171 |
| 141 | regulation of necrotic cell death (GO:0010939) | 2.46192977 |
| 142 | regulation of cofactor metabolic process (GO:0051193) | 2.46027446 |
| 143 | regulation of coenzyme metabolic process (GO:0051196) | 2.46027446 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.45824726 |
| 145 | urea metabolic process (GO:0019627) | 2.45272938 |
| 146 | regulation of defense response to virus by virus (GO:0050690) | 2.45268215 |
| 147 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.44843415 |
| 148 | regulation of ARF GTPase activity (GO:0032312) | 2.43738899 |
| 149 | regulation of extracellular matrix disassembly (GO:0010715) | 2.43116934 |
| 150 | regulation of cholesterol homeostasis (GO:2000188) | 2.42486670 |
| 151 | GDP-mannose metabolic process (GO:0019673) | 2.42032725 |
| 152 | gamete generation (GO:0007276) | 2.40299216 |
| 153 | modulation by virus of host process (GO:0019054) | 2.40137057 |
| 154 | glycolipid catabolic process (GO:0019377) | 2.39359983 |
| 155 | neutrophil activation involved in immune response (GO:0002283) | 2.37359814 |
| 156 | nitrogen cycle metabolic process (GO:0071941) | 2.37203402 |
| 157 | protein retention in ER lumen (GO:0006621) | 2.37175149 |
| 158 | germinal center formation (GO:0002467) | 2.37030064 |
| 159 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.34950260 |
| 160 | regulation of cholesterol storage (GO:0010885) | 2.34719776 |
| 161 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.32811912 |
| 162 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.30454881 |
| 163 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.30313007 |
| 164 | hyaluronan catabolic process (GO:0030214) | 2.29559146 |
| 165 | low-density lipoprotein particle clearance (GO:0034383) | 2.25800802 |
| 166 | positive regulation of protein dephosphorylation (GO:0035307) | 2.25646637 |
| 167 | positive thymic T cell selection (GO:0045059) | 2.24669992 |
| 168 | activation of MAPKKK activity (GO:0000185) | 2.24548347 |
| 169 | sexual reproduction (GO:0019953) | 2.23534263 |
| 170 | detection of external biotic stimulus (GO:0098581) | 2.23277025 |
| 171 | regulation of leukocyte degranulation (GO:0043300) | 2.22526139 |
| 172 | regulation of necroptotic process (GO:0060544) | 2.21159544 |
| 173 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.20286302 |
| 174 | basement membrane organization (GO:0071711) | 2.19821992 |
| 175 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.18888815 |
| 176 | negative regulation of necroptotic process (GO:0060546) | 2.18272451 |
| 177 | positive regulation of myotube differentiation (GO:0010831) | 2.16105201 |
| 178 | angiotensin maturation (GO:0002003) | 2.16090856 |
| 179 | thymic T cell selection (GO:0045061) | 2.15785796 |
| 180 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.15552542 |
| 181 | response to type I interferon (GO:0034340) | 2.15488738 |
| 182 | type I interferon signaling pathway (GO:0060337) | 2.14397523 |
| 183 | cellular response to type I interferon (GO:0071357) | 2.14397523 |
| 184 | adhesion of symbiont to host (GO:0044406) | 2.14262231 |
| 185 | adherens junction assembly (GO:0034333) | 2.13852306 |
| 186 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.12369741 |
| 187 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.11814496 |
| 188 | cell-substrate adherens junction assembly (GO:0007045) | 2.11589647 |
| 189 | focal adhesion assembly (GO:0048041) | 2.11589647 |
| 190 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.11423750 |
| 191 | epithelial cell-cell adhesion (GO:0090136) | 2.11303131 |
| 192 | adenosine receptor signaling pathway (GO:0001973) | 2.11156631 |
| 193 | glucose 6-phosphate metabolic process (GO:0051156) | 2.10547244 |
| 194 | response to muramyl dipeptide (GO:0032495) | 2.10266318 |
| 195 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.10220088 |
| 196 | regulation of superoxide anion generation (GO:0032928) | 2.08825906 |
| 197 | negative regulation of innate immune response (GO:0045824) | 2.08746390 |
| 198 | cell-cell junction maintenance (GO:0045217) | 2.08689928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.43970626 |
| 2 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 3.98853066 |
| 3 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.94478795 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89923967 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78073593 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.62144326 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46844571 |
| 8 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.43686870 |
| 9 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.36200936 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34753997 |
| 11 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.27720211 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.26806763 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.26570342 |
| 14 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.20919065 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.17696913 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.16557916 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.11928985 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.08367532 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.03338635 |
| 20 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.02443953 |
| 21 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.01083596 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.96578377 |
| 23 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90158319 |
| 24 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.89438037 |
| 25 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.82131442 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.78882470 |
| 27 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.77969869 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.67259746 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.66027532 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.65530232 |
| 31 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.63596917 |
| 32 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63055506 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.62870497 |
| 34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62830405 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.62521345 |
| 36 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.60592567 |
| 37 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58556981 |
| 38 | MAF_26560356_Chip-Seq_TH1_Human | 1.56126915 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.55509780 |
| 40 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54554021 |
| 41 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53826905 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53123909 |
| 43 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51319134 |
| 44 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.50001076 |
| 45 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.49724994 |
| 46 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.47358976 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46431447 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.45936982 |
| 49 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.45687055 |
| 50 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45167870 |
| 51 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.45082720 |
| 52 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44804084 |
| 53 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.44388983 |
| 54 | * MAF_26560356_Chip-Seq_TH2_Human | 1.44263008 |
| 55 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.42836003 |
| 56 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40326761 |
| 57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.39476062 |
| 58 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.38019488 |
| 59 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.37891743 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.37608573 |
| 61 | UTX_26944678_Chip-Seq_JUKART_Human | 1.37577928 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.36324210 |
| 63 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.35753533 |
| 64 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35271196 |
| 65 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.34944065 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33669396 |
| 67 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.33248130 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.32916052 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30973016 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.30958226 |
| 71 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28884312 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28733688 |
| 73 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28348826 |
| 74 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27877901 |
| 75 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27865181 |
| 76 | P68_20966046_ChIP-Seq_HELA_Human | 1.26121178 |
| 77 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.25803658 |
| 78 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25719597 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25625888 |
| 80 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.25244856 |
| 81 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24695652 |
| 82 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.23791206 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23420561 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.23182391 |
| 85 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22940430 |
| 86 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.22034262 |
| 87 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21659869 |
| 88 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21142295 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.21011903 |
| 90 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21001086 |
| 91 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20637549 |
| 92 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20637549 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20038975 |
| 94 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19581050 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17295402 |
| 96 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.15502891 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14951661 |
| 98 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14202631 |
| 99 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13544911 |
| 100 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13133943 |
| 101 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12185559 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11860456 |
| 103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11791772 |
| 104 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10239027 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10151450 |
| 106 | * FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09761935 |
| 107 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.09745861 |
| 108 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09656692 |
| 109 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.09519258 |
| 110 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09194028 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.09052080 |
| 112 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08693276 |
| 113 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.08658484 |
| 114 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07724254 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.07518401 |
| 116 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07470834 |
| 117 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07355946 |
| 118 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07130378 |
| 119 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07068500 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.06781898 |
| 121 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.06653469 |
| 122 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05981222 |
| 123 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05734046 |
| 124 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.02991169 |
| 125 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02866679 |
| 126 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02217385 |
| 127 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.02084613 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02056804 |
| 129 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01947741 |
| 130 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.01840509 |
| 131 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01834224 |
| 132 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.01637748 |
| 133 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01141235 |
| 134 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 1.00782379 |
| 135 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00628080 |
| 136 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98773352 |
| 137 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97477065 |
| 138 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97336925 |
| 139 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.96101227 |
| 140 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.96023923 |
| 141 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95733380 |
| 142 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.95532109 |
| 143 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94044532 |
| 144 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93349048 |
| 145 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.92759477 |
| 146 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91890316 |
| 147 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.90903209 |
| 148 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.90521980 |
| 149 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88155513 |
| 150 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.87026177 |
| 151 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.86654196 |
| 152 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86317644 |
| 153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.86316978 |
| 154 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.86222834 |
| 155 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85567599 |
| 156 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85567599 |
| 157 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84711444 |
| 158 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84668225 |
| 159 | GATA2_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.84374842 |
| 160 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.84059453 |
| 161 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.83896115 |
| 162 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.82234248 |
| 163 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82057039 |
| 164 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.82050474 |
| 165 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.81984722 |
| 166 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81960109 |
| 167 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.81728764 |
| 168 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81514456 |
| 169 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81391942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 6.39858975 |
| 2 | MP0003646_muscle_fatigue | 4.41971287 |
| 3 | MP0005451_abnormal_body_composition | 3.66996568 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.50414630 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.47821698 |
| 6 | MP0005058_abnormal_lysosome_morphology | 3.36077406 |
| 7 | MP0009840_abnormal_foam_cell | 3.25228569 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.19258271 |
| 9 | MP0000751_myopathy | 3.08486166 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.64444136 |
| 11 | MP0003436_decreased_susceptibility_to | 2.62277890 |
| 12 | MP0003303_peritoneal_inflammation | 2.59262342 |
| 13 | MP0004233_abnormal_muscle_weight | 2.46094174 |
| 14 | MP0005670_abnormal_white_adipose | 2.43043062 |
| 15 | MP0004130_abnormal_muscle_cell | 2.38450583 |
| 16 | MP0004036_abnormal_muscle_relaxation | 2.38279621 |
| 17 | MP0003698_abnormal_male_reproductive | 2.38202707 |
| 18 | MP0008260_abnormal_autophagy | 2.36456830 |
| 19 | MP0004510_myositis | 2.19490759 |
| 20 | MP0002822_catalepsy | 2.17688483 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.17524897 |
| 22 | MP0003635_abnormal_synaptic_transmissio | 2.12016081 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.11458411 |
| 24 | MP0008877_abnormal_DNA_methylation | 2.04511381 |
| 25 | MP0003183_abnormal_peptide_metabolism | 2.00105730 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.99288362 |
| 27 | MP0000749_muscle_degeneration | 1.98589568 |
| 28 | MP0004084_abnormal_cardiac_muscle | 1.96122868 |
| 29 | MP0009046_muscle_twitch | 1.89378467 |
| 30 | MP0002653_abnormal_ependyma_morphology | 1.88862918 |
| 31 | MP0001849_ear_inflammation | 1.87443060 |
| 32 | MP0001929_abnormal_gametogenesis | 1.83746500 |
| 33 | MP0002269_muscular_atrophy | 1.76091979 |
| 34 | MP0004947_skin_inflammation | 1.75900579 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.73322449 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.71971449 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.69606842 |
| 38 | MP0005025_abnormal_response_to | 1.69060523 |
| 39 | MP0003329_amyloid_beta_deposits | 1.67979306 |
| 40 | MP0005365_abnormal_bile_salt | 1.67349691 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.66539288 |
| 42 | MP0008569_lethality_at_weaning | 1.65644876 |
| 43 | MP0002064_seizures | 1.60999518 |
| 44 | MP0004270_analgesia | 1.60945098 |
| 45 | MP0003453_abnormal_keratinocyte_physiol | 1.59933184 |
| 46 | MP0003724_increased_susceptibility_to | 1.59537978 |
| 47 | MP0000013_abnormal_adipose_tissue | 1.59384409 |
| 48 | MP0006082_CNS_inflammation | 1.59113208 |
| 49 | MP0009278_abnormal_bone_marrow | 1.58044608 |
| 50 | MP0008961_abnormal_basal_metabolism | 1.57677083 |
| 51 | MP0002419_abnormal_innate_immunity | 1.56298286 |
| 52 | MP0009745_abnormal_behavioral_response | 1.54770967 |
| 53 | MP0004043_abnormal_pH_regulation | 1.54023612 |
| 54 | MP0009333_abnormal_splenocyte_physiolog | 1.52575078 |
| 55 | MP0004185_abnormal_adipocyte_glucose | 1.51529344 |
| 56 | MP0000858_altered_metastatic_potential | 1.51243226 |
| 57 | MP0004145_abnormal_muscle_electrophysio | 1.50514300 |
| 58 | MP0008438_abnormal_cutaneous_collagen | 1.50352118 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.49894952 |
| 60 | MP0005464_abnormal_platelet_physiology | 1.49773116 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 1.49649122 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.46813861 |
| 63 | MP0010155_abnormal_intestine_physiology | 1.44816221 |
| 64 | MP0000678_abnormal_parathyroid_gland | 1.41312758 |
| 65 | MP0003879_abnormal_hair_cell | 1.40573295 |
| 66 | MP0003279_aneurysm | 1.40091327 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.39928291 |
| 68 | MP0001835_abnormal_antigen_presentation | 1.39809069 |
| 69 | MP0002998_abnormal_bone_remodeling | 1.38808769 |
| 70 | MP0002877_abnormal_melanocyte_morpholog | 1.38294829 |
| 71 | MP0009785_altered_susceptibility_to | 1.37968515 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.37795396 |
| 73 | MP0000685_abnormal_immune_system | 1.37622682 |
| 74 | MP0001790_abnormal_immune_system | 1.37565294 |
| 75 | MP0005387_immune_system_phenotype | 1.37565294 |
| 76 | MP0003075_altered_response_to | 1.35954612 |
| 77 | MP0000747_muscle_weakness | 1.35339841 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.34963533 |
| 79 | MP0002572_abnormal_emotion/affect_behav | 1.33475591 |
| 80 | MP0002272_abnormal_nervous_system | 1.32218982 |
| 81 | MP0002736_abnormal_nociception_after | 1.30074111 |
| 82 | MP0005620_abnormal_muscle_contractility | 1.30052174 |
| 83 | MP0005646_abnormal_pituitary_gland | 1.29760062 |
| 84 | MP0005409_darkened_coat_color | 1.29743094 |
| 85 | MP0004858_abnormal_nervous_system | 1.29190305 |
| 86 | MP0001968_abnormal_touch/_nociception | 1.29002413 |
| 87 | MP0005330_cardiomyopathy | 1.27599389 |
| 88 | MP0002148_abnormal_hypersensitivity_rea | 1.26746020 |
| 89 | MP0003091_abnormal_cell_migration | 1.26029076 |
| 90 | MP0001984_abnormal_olfaction | 1.25512457 |
| 91 | MP0005076_abnormal_cell_differentiation | 1.22677216 |
| 92 | MP0002161_abnormal_fertility/fecundity | 1.21864536 |
| 93 | MP0002106_abnormal_muscle_physiology | 1.19860473 |
| 94 | MP0010329_abnormal_lipoprotein_level | 1.19243353 |
| 95 | MP0001958_emphysema | 1.17901523 |
| 96 | MP0000343_altered_response_to | 1.17712157 |
| 97 | MP0004085_abnormal_heartbeat | 1.17561230 |
| 98 | MP0005166_decreased_susceptibility_to | 1.16880959 |
| 99 | MP0004811_abnormal_neuron_physiology | 1.16876850 |
| 100 | MP0003880_abnormal_central_pattern | 1.16559743 |
| 101 | MP0005671_abnormal_response_to | 1.16465838 |
| 102 | MP0001873_stomach_inflammation | 1.16012582 |
| 103 | MP0002796_impaired_skin_barrier | 1.13921827 |
| 104 | MP0002723_abnormal_immune_serum | 1.13908004 |
| 105 | MP0003137_abnormal_impulse_conducting | 1.13588572 |
| 106 | MP0005023_abnormal_wound_healing | 1.13089554 |
| 107 | MP0001765_abnormal_ion_homeostasis | 1.12657823 |
| 108 | MP0002972_abnormal_cardiac_muscle | 1.12201325 |
| 109 | MP0005535_abnormal_body_temperature | 1.10889209 |
| 110 | MP0002452_abnormal_antigen_presenting | 1.08367677 |
| 111 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07069842 |
| 112 | MP0002078_abnormal_glucose_homeostasis | 1.07045898 |
| 113 | MP0001819_abnormal_immune_cell | 1.06385253 |
| 114 | MP0002420_abnormal_adaptive_immunity | 1.06270876 |
| 115 | MP0002735_abnormal_chemical_nociception | 1.06119523 |
| 116 | MP0001800_abnormal_humoral_immune | 1.05798769 |
| 117 | MP0005360_urolithiasis | 1.04830987 |
| 118 | MP0000759_abnormal_skeletal_muscle | 1.04723289 |
| 119 | MP0008469_abnormal_protein_level | 1.02329318 |
| 120 | MP0001845_abnormal_inflammatory_respons | 1.02065092 |
| 121 | MP0003828_pulmonary_edema | 1.01937599 |
| 122 | MP0001502_abnormal_circadian_rhythm | 1.01901788 |
| 123 | MP0002067_abnormal_sensory_capabilities | 1.01853597 |
| 124 | MP0001348_abnormal_lacrimal_gland | 1.01224337 |
| 125 | MP0003633_abnormal_nervous_system | 1.00751035 |
| 126 | MP0006035_abnormal_mitochondrial_morpho | 1.00690531 |
| 127 | MP0002933_joint_inflammation | 1.00648247 |
| 128 | MP0005666_abnormal_adipose_tissue | 1.00521770 |
| 129 | MP0002734_abnormal_mechanical_nocicepti | 0.97741212 |
| 130 | MP0005332_abnormal_amino_acid | 0.96476791 |
| 131 | MP0001486_abnormal_startle_reflex | 0.94388236 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.94113029 |
| 133 | MP0002118_abnormal_lipid_homeostasis | 0.93871025 |
| 134 | MP0005369_muscle_phenotype | 0.93777674 |
| 135 | MP0001544_abnormal_cardiovascular_syste | 0.92111947 |
| 136 | MP0005385_cardiovascular_system_phenoty | 0.92111947 |
| 137 | MP0004924_abnormal_behavior | 0.91894601 |
| 138 | MP0005386_behavior/neurological_phenoty | 0.91894601 |
| 139 | MP0000733_abnormal_muscle_development | 0.88696033 |
| 140 | MP0003172_abnormal_lysosome_physiology | 0.88327406 |
| 141 | MP0002210_abnormal_sex_determination | 0.87697851 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.86973867 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.86950179 |
| 144 | MP0003448_altered_tumor_morphology | 0.86688135 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.86654278 |
| 146 | MP0005645_abnormal_hypothalamus_physiol | 0.86599642 |
| 147 | MP0000249_abnormal_blood_vessel | 0.86324583 |
| 148 | MP0003656_abnormal_erythrocyte_physiolo | 0.86149390 |
| 149 | MP0008874_decreased_physiological_sensi | 0.85454963 |
| 150 | MP0003806_abnormal_nucleotide_metabolis | 0.85257267 |
| 151 | MP0003866_abnormal_defecation | 0.84984891 |
| 152 | MP0008875_abnormal_xenobiotic_pharmacok | 0.84576474 |
| 153 | MP0005375_adipose_tissue_phenotype | 0.84248377 |
| 154 | MP0005257_abnormal_intraocular_pressure | 0.81970390 |
| 155 | MP0000681_abnormal_thyroid_gland | 0.81598244 |
| 156 | MP0002557_abnormal_social/conspecific_i | 0.81092867 |
| 157 | MP0000716_abnormal_immune_system | 0.80688334 |
| 158 | MP0005310_abnormal_salivary_gland | 0.80126548 |
| 159 | MP0003195_calcinosis | 0.80065838 |
| 160 | MP0004264_abnormal_extraembryonic_tissu | 0.78580576 |
| 161 | MP0002733_abnormal_thermal_nociception | 0.78578598 |
| 162 | MP0002971_abnormal_brown_adipose | 0.78142893 |
| 163 | MP0008004_abnormal_stomach_pH | 0.78080686 |
| 164 | MP0001145_abnormal_male_reproductive | 0.78072812 |
| 165 | MP0001440_abnormal_grooming_behavior | 0.77578974 |
| 166 | MP0002066_abnormal_motor_capabilities/c | 0.77475249 |
| 167 | MP0005501_abnormal_skin_physiology | 0.77309199 |
| 168 | MP0005390_skeleton_phenotype | 0.76889296 |
| 169 | MP0005165_increased_susceptibility_to | 0.76431345 |
| 170 | MP0005423_abnormal_somatic_nervous | 0.76157177 |
| 171 | MP0000604_amyloidosis | 0.75322993 |
| 172 | MP0006138_congestive_heart_failure | 0.73689482 |
| 173 | MP0003953_abnormal_hormone_level | 0.73565530 |
| 174 | MP0001501_abnormal_sleep_pattern | 0.73257135 |
| 175 | MP0005448_abnormal_energy_balance | 0.72196427 |
| 176 | MP0010630_abnormal_cardiac_muscle | 0.70295892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 6.10622054 |
| 2 | Absent/shortened dynein arms (HP:0200106) | 5.99694507 |
| 3 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 5.99694507 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.50778904 |
| 5 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.12463378 |
| 6 | Myoglobinuria (HP:0002913) | 4.08614038 |
| 7 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.98701082 |
| 8 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.98701082 |
| 9 | Rhinitis (HP:0012384) | 3.73113469 |
| 10 | Infertility (HP:0000789) | 3.71949613 |
| 11 | Chronic bronchitis (HP:0004469) | 3.70641068 |
| 12 | Nasal polyposis (HP:0100582) | 3.60233856 |
| 13 | Exercise-induced muscle cramps (HP:0003710) | 3.49206554 |
| 14 | Distal lower limb muscle weakness (HP:0009053) | 3.35488796 |
| 15 | Abnormality of the lower motor neuron (HP:0002366) | 3.33062690 |
| 16 | Eczematoid dermatitis (HP:0000976) | 3.27376095 |
| 17 | Bundle branch block (HP:0011710) | 3.16145498 |
| 18 | Increased connective tissue (HP:0009025) | 3.13989950 |
| 19 | Abnormality of the nasal mucosa (HP:0000433) | 3.12044043 |
| 20 | Distal lower limb amyotrophy (HP:0008944) | 3.07462174 |
| 21 | Asymmetric septal hypertrophy (HP:0001670) | 3.07072249 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 2.96872053 |
| 23 | Sudden death (HP:0001699) | 2.93658396 |
| 24 | Ketoacidosis (HP:0001993) | 2.89330345 |
| 25 | Abnormal ciliary motility (HP:0012262) | 2.88087164 |
| 26 | Abnormality of macrophages (HP:0004311) | 2.80744215 |
| 27 | Ketosis (HP:0001946) | 2.79803050 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 2.78883512 |
| 29 | Myokymia (HP:0002411) | 2.77023716 |
| 30 | Myopathic facies (HP:0002058) | 2.76825066 |
| 31 | Thin bony cortex (HP:0002753) | 2.75871723 |
| 32 | Vertebral compression fractures (HP:0002953) | 2.75610816 |
| 33 | Pheochromocytoma (HP:0002666) | 2.72586994 |
| 34 | Cholecystitis (HP:0001082) | 2.71003413 |
| 35 | Abnormal gallbladder physiology (HP:0012438) | 2.71003413 |
| 36 | Achilles tendon contracture (HP:0001771) | 2.69613534 |
| 37 | Dysostosis multiplex (HP:0000943) | 2.69138885 |
| 38 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66672388 |
| 39 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66672388 |
| 40 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66672388 |
| 41 | Malnutrition (HP:0004395) | 2.58379659 |
| 42 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.57612970 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.57014729 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.54056621 |
| 45 | Rhabdomyolysis (HP:0003201) | 2.47892959 |
| 46 | Stridor (HP:0010307) | 2.46302571 |
| 47 | Neuroendocrine neoplasm (HP:0100634) | 2.45745707 |
| 48 | Bulbar palsy (HP:0001283) | 2.41331075 |
| 49 | Gout (HP:0001997) | 2.40735876 |
| 50 | Axonal loss (HP:0003447) | 2.40301289 |
| 51 | Postural instability (HP:0002172) | 2.40099813 |
| 52 | Protrusio acetabuli (HP:0003179) | 2.39612962 |
| 53 | Type 1 muscle fiber predominance (HP:0003803) | 2.37477259 |
| 54 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.36942957 |
| 55 | Epileptic encephalopathy (HP:0200134) | 2.35920290 |
| 56 | Increased variability in muscle fiber diameter (HP:0003557) | 2.35313089 |
| 57 | Recurrent abscess formation (HP:0002722) | 2.34307052 |
| 58 | Cellulitis (HP:0100658) | 2.33783125 |
| 59 | Bronchitis (HP:0012387) | 2.32795430 |
| 60 | Cerebral aneurysm (HP:0004944) | 2.32174378 |
| 61 | Gingivitis (HP:0000230) | 2.31413940 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.31173537 |
| 63 | Visual hallucinations (HP:0002367) | 2.30424970 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.29128808 |
| 65 | Ventricular fibrillation (HP:0001663) | 2.28649901 |
| 66 | Broad face (HP:0000283) | 2.28480690 |
| 67 | Upper limb amyotrophy (HP:0009129) | 2.27931894 |
| 68 | Distal upper limb amyotrophy (HP:0007149) | 2.27931894 |
| 69 | Abnormality of complement system (HP:0005339) | 2.27814364 |
| 70 | Cervical subluxation (HP:0003308) | 2.27729873 |
| 71 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.25924575 |
| 72 | Mucopolysacchariduria (HP:0008155) | 2.25924575 |
| 73 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.25288287 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.25288287 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.25288287 |
| 76 | Hypertriglyceridemia (HP:0002155) | 2.25253189 |
| 77 | Hyporeflexia of lower limbs (HP:0002600) | 2.24324968 |
| 78 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.23440683 |
| 79 | Dysmetric saccades (HP:0000641) | 2.22690466 |
| 80 | Purpura (HP:0000979) | 2.21375423 |
| 81 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.19217670 |
| 82 | Focal motor seizures (HP:0011153) | 2.16008072 |
| 83 | Colitis (HP:0002583) | 2.15515277 |
| 84 | Palpitations (HP:0001962) | 2.13952260 |
| 85 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.13730669 |
| 86 | Abnormality of the calf musculature (HP:0001430) | 2.11245004 |
| 87 | Increased cerebral lipofuscin (HP:0011813) | 2.11127012 |
| 88 | Central scotoma (HP:0000603) | 2.11067453 |
| 89 | Late onset (HP:0003584) | 2.10523670 |
| 90 | J-shaped sella turcica (HP:0002680) | 2.09591678 |
| 91 | Polydipsia (HP:0001959) | 2.08548566 |
| 92 | Abnormal drinking behavior (HP:0030082) | 2.08548566 |
| 93 | Heart block (HP:0012722) | 2.08109865 |
| 94 | Difficulty climbing stairs (HP:0003551) | 2.08025933 |
| 95 | Hyperventilation (HP:0002883) | 2.07734743 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.07177117 |
| 97 | Increased serum ferritin (HP:0003281) | 2.07172575 |
| 98 | Prolonged QT interval (HP:0001657) | 2.06557243 |
| 99 | Atrial fibrillation (HP:0005110) | 2.06076715 |
| 100 | Difficulty running (HP:0009046) | 2.04873622 |
| 101 | Deep venous thrombosis (HP:0002625) | 2.04329585 |
| 102 | Amyloidosis (HP:0011034) | 2.03232429 |
| 103 | Nephronophthisis (HP:0000090) | 2.02278210 |
| 104 | Supranuclear gaze palsy (HP:0000605) | 2.01466440 |
| 105 | Depression (HP:0000716) | 2.01313238 |
| 106 | Large for gestational age (HP:0001520) | 2.00629362 |
| 107 | Recurrent bacterial skin infections (HP:0005406) | 2.00291502 |
| 108 | Loss of speech (HP:0002371) | 1.99297462 |
| 109 | Ulnar bowing (HP:0003031) | 1.98645132 |
| 110 | Joint stiffness (HP:0001387) | 1.98362293 |
| 111 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98044248 |
| 112 | Myocardial infarction (HP:0001658) | 1.97035650 |
| 113 | Ankle clonus (HP:0011448) | 1.96892205 |
| 114 | Male infertility (HP:0003251) | 1.96349525 |
| 115 | Lower limb amyotrophy (HP:0007210) | 1.95550204 |
| 116 | Bronchiectasis (HP:0002110) | 1.95292414 |
| 117 | Gastrointestinal infarctions (HP:0005244) | 1.94709288 |
| 118 | Increased IgE level (HP:0003212) | 1.94608486 |
| 119 | Ragged-red muscle fibers (HP:0003200) | 1.94304111 |
| 120 | Obstructive sleep apnea (HP:0002870) | 1.94018292 |
| 121 | Left ventricular hypertrophy (HP:0001712) | 1.93953051 |
| 122 | Petechiae (HP:0000967) | 1.92854680 |
| 123 | Easy fatigability (HP:0003388) | 1.92337441 |
| 124 | Ventricular tachycardia (HP:0004756) | 1.91765064 |
| 125 | Muscle fiber splitting (HP:0003555) | 1.91005538 |
| 126 | Hyperacusis (HP:0010780) | 1.90808708 |
| 127 | Interstitial pulmonary disease (HP:0006530) | 1.90626985 |
| 128 | Emphysema (HP:0002097) | 1.88264869 |
| 129 | Impaired social interactions (HP:0000735) | 1.88210707 |
| 130 | Abnormal social behavior (HP:0012433) | 1.88210707 |
| 131 | Primary atrial arrhythmia (HP:0001692) | 1.88153500 |
| 132 | Hypoglycemic coma (HP:0001325) | 1.87084961 |
| 133 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.86826221 |
| 134 | Muscle fiber inclusion bodies (HP:0100299) | 1.86818663 |
| 135 | Xanthomatosis (HP:0000991) | 1.86587450 |
| 136 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.86412066 |
| 137 | Myotonia (HP:0002486) | 1.85786654 |
| 138 | Abnormal EKG (HP:0003115) | 1.85554745 |
| 139 | Complement deficiency (HP:0004431) | 1.83879621 |
| 140 | Syncope (HP:0001279) | 1.83721897 |
| 141 | EMG: myopathic abnormalities (HP:0003458) | 1.83711174 |
| 142 | Poor eye contact (HP:0000817) | 1.83614125 |
| 143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.83378368 |
| 144 | Recurrent otitis media (HP:0000403) | 1.83291744 |
| 145 | Neoplasm of the heart (HP:0100544) | 1.82675677 |
| 146 | Cholelithiasis (HP:0001081) | 1.82090688 |
| 147 | Obstructive lung disease (HP:0006536) | 1.81344296 |
| 148 | Chronic obstructive pulmonary disease (HP:0006510) | 1.81344296 |
| 149 | Spinal rigidity (HP:0003306) | 1.79807860 |
| 150 | Gastrointestinal inflammation (HP:0004386) | 1.79725672 |
| 151 | Abnormal atrioventricular conduction (HP:0005150) | 1.79718873 |
| 152 | Supraventricular tachycardia (HP:0004755) | 1.79439709 |
| 153 | Resting tremor (HP:0002322) | 1.78324970 |
| 154 | Impaired vibratory sensation (HP:0002495) | 1.77847020 |
| 155 | Nemaline bodies (HP:0003798) | 1.77490496 |
| 156 | Polycythemia (HP:0001901) | 1.77238240 |
| 157 | Oligomenorrhea (HP:0000876) | 1.76519630 |
| 158 | Status epilepticus (HP:0002133) | 1.76189155 |
| 159 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.75039607 |
| 160 | Flat acetabular roof (HP:0003180) | 1.74797944 |
| 161 | EMG: neuropathic changes (HP:0003445) | 1.74090081 |
| 162 | Impaired proprioception (HP:0010831) | 1.74060454 |
| 163 | Supraventricular arrhythmia (HP:0005115) | 1.73808268 |
| 164 | Thoracic kyphosis (HP:0002942) | 1.72554796 |
| 165 | Medial flaring of the eyebrow (HP:0010747) | 1.72204415 |
| 166 | Bone pain (HP:0002653) | 1.71824545 |
| 167 | Ventricular arrhythmia (HP:0004308) | 1.70872075 |
| 168 | Abnormal gallbladder morphology (HP:0012437) | 1.70662774 |
| 169 | Hyperammonemia (HP:0001987) | 1.70614216 |
| 170 | Abnormality of saccadic eye movements (HP:0000570) | 1.70549278 |
| 171 | Nuclear cataract (HP:0100018) | 1.69695886 |
| 172 | Focal seizures (HP:0007359) | 1.69581757 |
| 173 | Myositis (HP:0100614) | 1.69427123 |
| 174 | Progressive neurologic deterioration (HP:0002344) | 1.69328737 |
| 175 | Polygenic inheritance (HP:0010982) | 1.69269374 |
| 176 | Abnormality of the thoracic spine (HP:0100711) | 1.68769753 |
| 177 | Hyperparathyroidism (HP:0000843) | 1.68489551 |
| 178 | Aneurysm (HP:0002617) | 1.68418845 |
| 179 | Glomerulonephritis (HP:0000099) | 1.68041664 |
| 180 | Gastrointestinal dysmotility (HP:0002579) | 1.67819357 |
| 181 | Death in childhood (HP:0003819) | 1.67762725 |
| 182 | Fragile skin (HP:0001030) | 1.67417974 |
| 183 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.66612825 |
| 184 | Flattened epiphyses (HP:0003071) | 1.66307024 |
| 185 | Muscle stiffness (HP:0003552) | 1.66143772 |
| 186 | Anosmia (HP:0000458) | 1.65707290 |
| 187 | Inflammation of the large intestine (HP:0002037) | 1.65351164 |
| 188 | Abnormal urine output (HP:0012590) | 1.64871637 |
| 189 | Cerebral inclusion bodies (HP:0100314) | 1.63954483 |
| 190 | Dysdiadochokinesis (HP:0002075) | 1.63142304 |
| 191 | Gonadotropin excess (HP:0000837) | 1.62984471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PDK4 | 5.73659251 |
| 2 | PDK3 | 5.73659251 |
| 3 | PRKD3 | 4.84414000 |
| 4 | TESK1 | 3.38066403 |
| 5 | TRIB3 | 3.35429443 |
| 6 | PDK2 | 3.16916624 |
| 7 | ICK | 2.54894170 |
| 8 | IRAK3 | 2.54350691 |
| 9 | SMG1 | 2.25055687 |
| 10 | MAP2K3 | 2.08551684 |
| 11 | TESK2 | 2.02340570 |
| 12 | LMTK2 | 2.01571600 |
| 13 | PHKG2 | 2.00107470 |
| 14 | PHKG1 | 2.00107470 |
| 15 | MAP3K11 | 1.99324904 |
| 16 | PTK2B | 1.78270491 |
| 17 | NME2 | 1.77352389 |
| 18 | DAPK2 | 1.75895806 |
| 19 | WNK4 | 1.66493892 |
| 20 | STK38 | 1.59275159 |
| 21 | TBK1 | 1.58540574 |
| 22 | BCKDK | 1.56998343 |
| 23 | MAP3K4 | 1.49625673 |
| 24 | MST1R | 1.49245103 |
| 25 | EPHA2 | 1.48846512 |
| 26 | PKN2 | 1.47746787 |
| 27 | TAOK2 | 1.47376490 |
| 28 | PINK1 | 1.47226661 |
| 29 | MAP3K3 | 1.44896685 |
| 30 | NEK1 | 1.44511925 |
| 31 | CAMKK1 | 1.43277480 |
| 32 | TYK2 | 1.39292238 |
| 33 | TTN | 1.36568652 |
| 34 | EPHA4 | 1.29419819 |
| 35 | NTRK2 | 1.26650643 |
| 36 | EPHB1 | 1.26041029 |
| 37 | DAPK1 | 1.25377639 |
| 38 | BLK | 1.22180058 |
| 39 | SIK3 | 1.18540665 |
| 40 | DDR2 | 1.15975559 |
| 41 | MAP3K13 | 1.14855490 |
| 42 | ERN1 | 1.14414136 |
| 43 | MAP2K7 | 1.14265452 |
| 44 | NTRK3 | 1.10643469 |
| 45 | MINK1 | 1.10536367 |
| 46 | MYLK | 1.10298523 |
| 47 | PRKD2 | 1.09970837 |
| 48 | CCNB1 | 1.06893841 |
| 49 | PAK6 | 1.03557100 |
| 50 | CSK | 1.02606397 |
| 51 | IRAK4 | 1.02511558 |
| 52 | GRK6 | 1.02068168 |
| 53 | PDK1 | 1.00483995 |
| 54 | MARK1 | 0.96810779 |
| 55 | MAP3K9 | 0.96566535 |
| 56 | PAK4 | 0.95953573 |
| 57 | RIPK1 | 0.95181541 |
| 58 | MAP2K4 | 0.94103346 |
| 59 | SIK1 | 0.93234880 |
| 60 | TAOK1 | 0.90826658 |
| 61 | TNK2 | 0.89436374 |
| 62 | JAK3 | 0.87339715 |
| 63 | TYRO3 | 0.84983239 |
| 64 | PIM2 | 0.83275537 |
| 65 | SGK3 | 0.83247590 |
| 66 | PRKG2 | 0.82298075 |
| 67 | RPS6KC1 | 0.81618756 |
| 68 | RPS6KL1 | 0.81618756 |
| 69 | PDGFRA | 0.81146179 |
| 70 | CAMK1G | 0.80552633 |
| 71 | INSRR | 0.78427588 |
| 72 | KDR | 0.78094005 |
| 73 | SGK494 | 0.76980123 |
| 74 | SGK223 | 0.76980123 |
| 75 | SGK2 | 0.76856980 |
| 76 | RPS6KA2 | 0.76772991 |
| 77 | MAP3K6 | 0.76489029 |
| 78 | CAMKK2 | 0.76203305 |
| 79 | PDPK1 | 0.75809246 |
| 80 | IRAK2 | 0.73928382 |
| 81 | OBSCN | 0.73832421 |
| 82 | MAPK11 | 0.72680746 |
| 83 | PRKAA1 | 0.72657160 |
| 84 | MAP2K6 | 0.70621899 |
| 85 | BMX | 0.67560389 |
| 86 | MAP2K2 | 0.67484468 |
| 87 | FES | 0.66838569 |
| 88 | PRKCH | 0.66501660 |
| 89 | MAP3K14 | 0.66089782 |
| 90 | BRAF | 0.66084206 |
| 91 | MTOR | 0.65679812 |
| 92 | MUSK | 0.65214101 |
| 93 | CDK5 | 0.64848219 |
| 94 | SIK2 | 0.63228425 |
| 95 | NTRK1 | 0.63082130 |
| 96 | ABL2 | 0.62421226 |
| 97 | TGFBR2 | 0.62407470 |
| 98 | IKBKE | 0.61030025 |
| 99 | DYRK1B | 0.60596253 |
| 100 | CDK19 | 0.59952594 |
| 101 | RPS6KA6 | 0.59707797 |
| 102 | JAK1 | 0.59646256 |
| 103 | MOS | 0.59160426 |
| 104 | HCK | 0.58968935 |
| 105 | BTK | 0.58197680 |
| 106 | MAPKAPK3 | 0.57703950 |
| 107 | CAMK1 | 0.57660041 |
| 108 | PTK2 | 0.57148332 |
| 109 | MAP3K7 | 0.56051627 |
| 110 | PRKCG | 0.54776559 |
| 111 | KSR2 | 0.54774122 |
| 112 | EEF2K | 0.54153271 |
| 113 | MAP3K8 | 0.49710458 |
| 114 | CAMK4 | 0.49131570 |
| 115 | LRRK2 | 0.48409557 |
| 116 | MARK2 | 0.47464083 |
| 117 | TXK | 0.46980759 |
| 118 | HIPK2 | 0.46738206 |
| 119 | DMPK | 0.45711950 |
| 120 | RET | 0.43971545 |
| 121 | MAPK12 | 0.42422952 |
| 122 | DAPK3 | 0.42086880 |
| 123 | IKBKB | 0.41842469 |
| 124 | PAK3 | 0.41325783 |
| 125 | TAOK3 | 0.41086936 |
| 126 | MAP3K10 | 0.40393735 |
| 127 | MAPK4 | 0.39477122 |
| 128 | WNK1 | 0.39462949 |
| 129 | PRKD1 | 0.39203784 |
| 130 | MAPK7 | 0.38494501 |
| 131 | SYK | 0.38190337 |
| 132 | CDK12 | 0.37902193 |
| 133 | UHMK1 | 0.36831265 |
| 134 | CAMK2A | 0.36529097 |
| 135 | ILK | 0.36312348 |
| 136 | MAP4K1 | 0.35803016 |
| 137 | MAP3K1 | 0.35670762 |
| 138 | FGR | 0.35327134 |
| 139 | PRPF4B | 0.34204337 |
| 140 | PRKACG | 0.33414894 |
| 141 | MAP3K12 | 0.32995038 |
| 142 | PTK6 | 0.31711189 |
| 143 | PRKCZ | 0.31557857 |
| 144 | CDK18 | 0.31529413 |
| 145 | CDC42BPA | 0.30916902 |
| 146 | RIPK4 | 0.30702213 |
| 147 | MAPK15 | 0.30349121 |
| 148 | CDK15 | 0.29015866 |
| 149 | RPS6KB1 | 0.28568583 |
| 150 | STK11 | 0.28304456 |
| 151 | WNK3 | 0.27759524 |
| 152 | CAMK2G | 0.27706840 |
| 153 | STK39 | 0.27305204 |
| 154 | FGFR4 | 0.26382763 |
| 155 | ZAP70 | 0.26162613 |
| 156 | RPS6KA3 | 0.25779311 |
| 157 | FLT3 | 0.25045716 |
| 158 | ARAF | 0.24819705 |
| 159 | CAMK2D | 0.24632317 |
| 160 | MAPK13 | 0.24227553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.94488034 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.27669638 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.95731809 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.86130279 |
| 5 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.84307837 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.57636395 |
| 7 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.27949541 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.25913070 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.21875179 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.17369424 |
| 11 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.13844303 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.08406025 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01444705 |
| 14 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.94127189 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93288239 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.84611140 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.76413779 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.69182588 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68552202 |
| 20 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.66052098 |
| 21 | Insulin secretion_Homo sapiens_hsa04911 | 1.64159639 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59749684 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.55211061 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.53074342 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.51989565 |
| 26 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.50540757 |
| 27 | Sulfur relay system_Homo sapiens_hsa04122 | 1.50124883 |
| 28 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.49715304 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.47464242 |
| 30 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.46382505 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.44893773 |
| 32 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.44701834 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.44366499 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44017685 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43741367 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.42430714 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42258491 |
| 38 | Circadian entrainment_Homo sapiens_hsa04713 | 1.40587287 |
| 39 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40266155 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39528118 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.39445333 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37152665 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.30053005 |
| 44 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26747862 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 1.25331013 |
| 46 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.24125044 |
| 47 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.21145136 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.16555881 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.16392481 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.12650420 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.11301917 |
| 52 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.10685650 |
| 53 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.10322549 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 1.10063726 |
| 55 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.10052988 |
| 56 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.09589329 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08964005 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08599666 |
| 59 | Morphine addiction_Homo sapiens_hsa05032 | 1.08277003 |
| 60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.06547773 |
| 61 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06513480 |
| 62 | Renin secretion_Homo sapiens_hsa04924 | 1.05957350 |
| 63 | Nicotine addiction_Homo sapiens_hsa05033 | 1.04720711 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02749728 |
| 65 | Malaria_Homo sapiens_hsa05144 | 1.01376291 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00075098 |
| 67 | Hepatitis C_Homo sapiens_hsa05160 | 0.99702950 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99662058 |
| 69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.99465586 |
| 70 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98564005 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.98043306 |
| 72 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.97500628 |
| 73 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96237030 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94781886 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.94661761 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.93787363 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.93753210 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92997836 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.92073021 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91720312 |
| 81 | Allograft rejection_Homo sapiens_hsa05330 | 0.91357812 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.90890070 |
| 83 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.88492626 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88333386 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.87811659 |
| 86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86511086 |
| 87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86222658 |
| 88 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86220947 |
| 89 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.85731238 |
| 90 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.85726617 |
| 91 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85476710 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.85468298 |
| 93 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85451091 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85396421 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.84369693 |
| 96 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.84106289 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82995605 |
| 98 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.82943191 |
| 99 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82335163 |
| 100 | Bile secretion_Homo sapiens_hsa04976 | 0.82092841 |
| 101 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81221278 |
| 102 | Salivary secretion_Homo sapiens_hsa04970 | 0.81142856 |
| 103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80857033 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.80801469 |
| 105 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80540713 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.79597637 |
| 107 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78734856 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77943904 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.76878276 |
| 110 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.74964562 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.74529989 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.74237384 |
| 113 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73902842 |
| 114 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73863954 |
| 115 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73056580 |
| 116 | Platelet activation_Homo sapiens_hsa04611 | 0.72007074 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.71710682 |
| 118 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71298760 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.70761448 |
| 120 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68337493 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.67319779 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.66815143 |
| 123 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65464822 |
| 124 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65381247 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.63747857 |
| 126 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63179906 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60961290 |
| 128 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60576729 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60562483 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.59295132 |
| 131 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58607755 |
| 132 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57064707 |
| 133 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55890963 |
| 134 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54998563 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54633271 |
| 136 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.53494367 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53371500 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52992006 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52936045 |
| 140 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52842255 |
| 141 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52507589 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52413840 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.52212794 |
| 144 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51757638 |
| 145 | ABC transporters_Homo sapiens_hsa02010 | 0.50633991 |
| 146 | Glioma_Homo sapiens_hsa05214 | 0.50551424 |
| 147 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50272280 |
| 148 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50051316 |
| 149 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49793855 |
| 150 | Taste transduction_Homo sapiens_hsa04742 | 0.49611998 |
| 151 | Measles_Homo sapiens_hsa05162 | 0.48790604 |
| 152 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48237125 |
| 153 | Galactose metabolism_Homo sapiens_hsa00052 | 0.46810945 |
| 154 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.46463983 |
| 155 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46176887 |
| 156 | Legionellosis_Homo sapiens_hsa05134 | 0.44970160 |
| 157 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.44616704 |
| 158 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44498669 |
| 159 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44462821 |
| 160 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.44394151 |
| 161 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43940478 |
| 162 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.43860358 |
| 163 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.39101852 |
| 164 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38738389 |
| 165 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37671742 |
| 166 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37198226 |
| 167 | Lysine degradation_Homo sapiens_hsa00310 | 0.34744633 |
| 168 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32760901 |

